Participant flow

Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility · Source last updated 2016-03-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Erythromycin 200 mg i.v. suspension

   id

   FG000

   title

   Erythromycin

2. description

   Matching placebo i.v. suspension

   id

   FG001

   title

   Placebo

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         19

      2. group Id

         FG001

         num Subjects

         21

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         19

      2. group Id

         FG001

         num Subjects

         21

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

There was no wash out or run-in period following participant enrollment.

recruitment Details

Recruitment period: 07/09/2011 - 03/13/2013 Location: Mayo Clinic, Rochester, Minnesota

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice